HomeNECLIFE • NSE
add
Nectar Lifesciences Ltd
Previous close
₹32.30
Day range
₹31.81 - ₹33.91
Year range
₹26.15 - ₹56.50
Market cap
7.60B INR
Avg Volume
809.82K
P/E ratio
71.15
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 4.28B | 7.52% |
Operating expense | 1.04B | 5.51% |
Net income | 55.99M | 451.45% |
Net profit margin | 1.31 | 403.85% |
Earnings per share | — | — |
EBITDA | 432.89M | 61.08% |
Effective tax rate | 35.39% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 187.35M | -7.94% |
Total assets | 21.83B | 1.89% |
Total liabilities | 11.05B | 2.80% |
Total equity | 10.78B | — |
Shares outstanding | 223.96M | — |
Price to book | 0.67 | — |
Return on assets | — | — |
Return on capital | 4.07% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 55.99M | 451.45% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Headquarters
Website
Employees
1,686
